Related Experiment Video
Updated: Apr 20, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.8K
Intravenous thrombolysis for acute ischemic stroke.
1Stroke unit, Sainte-Anne hospital, 1, rue Cabanis, 75014 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France; Inserm UMR S894, France.
Diagnostic and Interventional Imaging
|December 4, 2014
Summary
Intravenous thrombolysis (IVT) with alteplase is standard for acute ischemic stroke, offering significant benefits when administered early. Research aims to expand IVT eligibility and improve recanalization rates for better patient outcomes.
Area of Science:
- Neurology
- Emergency Medicine
- Pharmacology
Background:
- Intravenous thrombolysis (IVT) with alteplase is the established treatment for acute ischemic stroke.
- Early administration of IVT significantly enhances its effectiveness and safety profile.
- IVT offers a 10% absolute risk reduction in 3-month handicap or death, with a 2-7% risk of symptomatic intracranial hemorrhage.
Purpose of the Study:
- To explore methods for treating a larger patient cohort by addressing IVT contraindications.
- To evaluate combined or alternative treatments for achieving higher early recanalization rates.
- To optimize acute ischemic stroke management through advanced therapeutic strategies.
Main Methods:
- Review of current clinical practices and research in acute ischemic stroke treatment.
- Analysis of strategies to overcome contraindications for IVT.
- Assessment of novel therapeutic combinations and alternatives to alteplase.
Main Results:
- Early IVT administration is crucial for maximizing benefits in acute ischemic stroke.
- Ongoing research focuses on expanding patient eligibility for thrombolysis.
- Investigating new treatment protocols to improve reperfusion rates is a key research direction.
Conclusions:
- Alteplase-based IVT is a cornerstone therapy for acute ischemic stroke, particularly when given promptly.
- Future research is essential to broaden treatment access and enhance efficacy through innovative approaches.
- Optimizing recanalization remains a critical goal in improving outcomes for stroke patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
475
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
475
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
721
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
721
01:15Ischemic Stroke l: Introduction
7
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
7
01:15Ischemic Stroke ll: Pathophysiology
5
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
5
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.9K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K